Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Tatva Chintan Pharma Chem IPO is a book build issue of ₹500.00 crores. The issue is a combination of fresh issue of 0.21 crore shares aggregating to ₹225.00 crores and offer for sale of 0.25 crore shares aggregating to ₹275.00 crores.
Tatva Chintan Pharma Chem IPO bidding started from Jul 16, 2021 and ended on Jul 20, 2021. The allotment for Tatva Chintan Pharma Chem IPO was finalized on Jul 26, 2021. The shares got listed on BSE, NSE on Jul 29, 2021.
Tatva Chintan Pharma Chem IPO price band is set at ₹1083.00 per share . The lot size for an application is 13. The minimum amount of investment required by an retail is ₹13,949 (13 shares). The lot size investment for sNII is 15 lots (195 shares), amounting to ₹2,11,185, and for bNII, it is 72 lots (936 shares), amounting to ₹10,13,688.
ICICI Securities Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Tatva Chintan Pharma Chem IPO RHP for detailed Information.
| IPO Date | July 16, 2021 to July 20, 2021 |
| Listing Date | July 29, 2021 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹1073 to ₹1083 per share |
| Issue Price Final | ₹1083 per share |
| Lot Size | 13 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 46,16,804 shares (aggregating up to ₹500.00 Cr) |
| Fresh Issue | 20,77,562 shares (aggregating up to ₹225.00 Cr) |
| Offer for Sale | 25,39,242 shares of ₹10 (aggregating up to ₹275.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 2,00,87,500 shares |
| Share Holding Post Issue | 2,21,65,062 shares |
Tatva Chintan Pharma IPO offers total 46,16,804 shares. Out of which 23,08,401 (50.00%) allocated to QIB, 9,23,361 (20.00%) allocated to QIB, 6,92,521 (15.00%) allocated to NII, 16,15,882 (35.00%) allocated to RII and 13,85,040 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 23,08,401 (50.00%) | NA |
| − Anchor Investor Shares Offered | 13,85,040 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 9,23,361 (20.00%) | NA |
| NII (HNI) Shares Offered | 6,92,521 (15.00%) | NA |
| Retail Shares Offered | 16,15,882 (35.00%) | 1,24,298 |
| Total Shares Offered | 46,16,804 (100.00%) |
Tatva Chintan Pharma Chem IPO opens on July 16, 2021, and closes on July 20, 2021.
| IPO Open Date | Fri, Jul 16, 2021 |
| IPO Close Date | Tue, Jul 20, 2021 |
| Tentative Allotment | Mon, Jul 26, 2021 |
| Initiation of Refunds | Tue, Jul 27, 2021 |
| Credit of Shares to Demat | Wed, Jul 28, 2021 |
| Tentative Listing Date | Thu, Jul 29, 2021 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Jul 20, 2021 |
Investors can bid for a minimum of 13 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 13 | ₹14,079 |
| Retail (Max) | 14 | 182 | ₹1,97,106 |
| S-HNI (Min) | 15 | 195 | ₹2,11,185 |
| S-HNI (Max) | 71 | 923 | ₹9,99,609 |
| B-HNI (Min) | 72 | 936 | ₹10,13,688 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Competitive strengths
| Particulars | For the year/period ended (₹ in million) | ||||
|---|---|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |||
| Total Assets | 3,148.03 | 2,489.38 | 1,875.08 | ||
| Total Revenue | 3,062.92 | 2,646.22 | 2,068.01 | ||
| Profit After Tax | 522.62 | 377.89 | 205.43 | ||
The Company Tatva Chintan Pharma Chem IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Funding capital expenditure requirements for expansion of our Dahej Manufacturing Facility | 147.10 |
| 2 | Funding capital expenditure requirements for upgradation at our R&D facility in Vadodara; and | 23.97 |
| 3 | General corporate purposes | 36.21 |
[Dilip Davda] The company is in a fast forward mode and the issue is reasonably priced. The green chemical industry is fancied by investors across the board. Investment may be considered for short to long term rewards. Read detail review...
| Listing Date | July 29, 2021 |
| BSE Script Code | 543321 |
| NSE Symbol | TATVA |
| ISIN | INE0GK401011 |
| Final Issue Price | ₹1083 per share |
| BSE Listing Group | B |
Tatva Chintan Pharma Chem Ltd.
Plot No. 502 / 17, GIDC Estate, Ankleshwar,
Bharuch, Gujarat - 393002, India
Bharuch, Gujarat
Phone: +91 75730 46951
Email: cs@tatvachintan.com
Website: http://www.tatvachintan.com/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: tatva.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Tatva Chintan Pharma Chem IPO is a main-board IPO of 46,16,804 equity shares of the face value of ₹10 aggregating up to ₹500.00 Crores. The issue is priced at ₹1083 per share. The minimum order quantity is 13.
The IPO opens on July 16, 2021, and closes on July 20, 2021.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Tatva Chintan Pharma Chem IPO using UPI as a payment gateway. Zerodha customers can apply in Tatva Chintan Pharma Chem IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Tatva Chintan Pharma Chem IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Tatva Chintan Pharma Chem IPO opens on July 16, 2021 and closes on July 20, 2021.
Tatva Chintan Pharma Chem IPO lot size is 13, and the minimum amount required for application is ₹14,079.
You can apply in Tatva Chintan Pharma Chem IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Tatva Chintan Pharma Chem IPO will be done on Monday, July 26, 2021, and the allotted shares will be credited to your demat account by Wednesday, July 28, 2021. Check the Tatva Chintan Pharma Chem IPO allotment status.
The Tatva Chintan Pharma Chem IPO listing date is on Thursday, July 29, 2021.
Useful Articles
RHP